| (210) | Number of the EPO application | 20789680 |
| (220) | Filing date of the EPO application | 2020.09.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 46/2023, 2023.11.15 |
| (110) | EPO patent number | 4038060 |
| (21) | Number of the application | e 2022 0872 |
| (71) | Name(s) of applicant(s), code of the country | PFIZER INC., US; |
| (72) | Name(s) of inventor(s), code of the country | EDMONDS David James, US;
FILIPSKI Kevin James, US;
FUTATSUGI Kentaro, US;
GARNSEY Michelle Renee, US;
LEE Jack Chang Hung, US;
SMALTZ Daniel Jonathan, US; |
| (73) | Name(s) of owner(s), code of the country | PFIZER INC., US; |
| (54) | Title of the invention | DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/14 (2006.01.01); A61P 3/00 (2006.01.01); A61K 31/506 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2022.08.31 |
| (30) | Priority | 201962911094 P, 2019.10.04, US; 202063074123 P, 2020.09.03, US |
| (86) | International application | PCT/IB2020/059145, 2020.09.30 |
| (87) | International publication | WO 2021/064590, 2021.04.08 |